Roivant Sciences Ltd (ROIV) Insider Trading
- $417,605,146.60
- $811,374,977.23
- March 17, 2026
- Eric Venker
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 17, 2026 | CEO | 200,000 | $28.24 | Sell | $5,648,000.00 | |
| March 16, 2026 | Director | 41,861 | $28.68 | Sell | $1,200,573.48 | |
| Feb. 23, 2026 | Insider | 587,390 | $27.51 | Sell | $16,159,098.90 | |
| Feb. 20, 2026 | Insider | 1,012,610 | $27.15 | Sell | $27,492,361.50 | |
| Feb. 13, 2026 | CEO | 200,000 | $26.49 | Sell | $5,298,000.00 | |
| Feb. 13, 2026 | Director | 375,784 | $26.50 | Sell | $9,958,276.00 | |
| Feb. 11, 2026 | Director | 425,000 | $26.67 | Sell | $11,334,750.00 | |
| Feb. 9, 2026 | Insider | 339,441 | $26.47 | Sell | $8,985,003.27 | |
| Sept. 23, 2025 | CEO | 611,000 | $14.83 | Sell | $9,061,130.00 | |
| Sept. 22, 2025 | CEO | 416,182 | $14.99 | Sell | $6,238,568.18 | |
| Sept. 19, 2025 | CEO | 683,818 | $14.95 | Sell | $10,223,079.10 | |
| Sept. 18, 2025 | CEO | 3,315 | $15.07 | Buy | $49,957.05 | |
| Sept. 5, 2025 | Major Shareholder | 385,816 | $12.96 | Sell | $5,000,175.36 | |
| Sept. 4, 2025 | Major Shareholder | 194,933 | $12.92 | Sell | $2,518,534.36 | |
| Sept. 3, 2025 | Major Shareholder | 1,195,000 | $12.50 | Sell | $14,937,500.00 | |
| Aug. 20, 2025 | CEO | 100,000 | $11.72 | Sell | $1,172,000.00 | |
| July 21, 2025 | CEO | 100,000 | $11.52 | Sell | $1,152,000.00 | |
| June 20, 2025 | Major Shareholder | 577,007 | $11.46 | Sell | $6,612,500.22 | |
| June 20, 2025 | COO | 100,000 | $11.45 | Sell | $1,145,000.00 | |
| June 18, 2025 | Major Shareholder | 565,266 | $11.45 | Sell | $6,472,295.70 | |
| June 6, 2025 | Major Shareholder | 200,800 | $11.19 | Sell | $2,246,952.00 | |
| June 4, 2025 | Major Shareholder | 547,430 | $11.34 | Sell | $6,207,856.20 | |
| June 3, 2025 | COO | 566,278 | $11.22 | Sell | $6,353,639.16 | |
| June 2, 2025 | COO | 433,722 | $11.07 | Sell | $4,801,302.54 | |
| May 20, 2025 | COO | 100,000 | $10.95 | Sell | $1,095,000.00 | |
| May 6, 2025 | Major Shareholder | 273,959 | $11.47 | Sell | $3,142,309.73 | |
| April 21, 2025 | COO | 100,000 | $10.22 | Sell | $1,022,000.00 | |
| March 24, 2025 | COO | 434,478 | $10.82 | Sell | $4,701,051.96 | |
| March 20, 2025 | COO | 315,522 | $11.06 | Sell | $3,489,673.32 | |
| Feb. 20, 2025 | COO | 100,000 | $10.65 | Sell | $1,065,000.00 | |
| Feb. 13, 2025 | CAO | 227,500 | $10.43 | Sell | $2,372,825.00 | |
| Feb. 13, 2025 | COO | 218,041 | $10.42 | Sell | $2,271,987.22 | |
| Jan. 21, 2025 | COO | 100,000 | $11.28 | Sell | $1,128,000.00 | |
| Jan. 13, 2025 | Director | 16,845,010 | $20.00 | Buy | $336,900,200.00 | |
| Dec. 30, 2024 | COO | 177,704 | $11.54 | Sell | $2,050,704.16 | |
| Dec. 27, 2024 | COO | 176,900 | $11.82 | Sell | $2,090,958.00 | |
| Dec. 26, 2024 | CIO | 689,495 | $12.01 | Sell | $8,280,834.95 | |
| Dec. 24, 2024 | CIO | 185,946 | $12.00 | Sell | $2,231,352.00 | |
| Dec. 20, 2024 | COO | 100,000 | $11.49 | Sell | $1,149,000.00 | |
| Dec. 18, 2024 | CIO | 412,584 | $12.05 | Sell | $4,971,637.20 | |
| Nov. 20, 2024 | COO | 100,000 | $11.32 | Sell | $1,132,000.00 | |
| Oct. 21, 2024 | COO | 100,000 | $11.65 | Sell | $1,165,000.00 | |
| Sept. 26, 2024 | Director | 876,000 | $11.82 | Sell | $10,354,320.00 | |
| Sept. 24, 2024 | Director | 368,052 | $11.62 | Sell | $4,276,764.24 | |
| Sept. 23, 2024 | CAO | 250,000 | $11.89 | Sell | $2,972,500.00 | |
| Sept. 23, 2024 | CEO | 1,983,257 | $11.79 | Sell | $23,382,600.03 | |
| Feb. 9, 2024 | COO | 96,950 | $10.92 | Sell | $1,058,694.00 | |
| Jan. 2, 2024 | Major Shareholder | 3,000,000 | $11.05 | Sell | $33,150,000.00 | |
| Oct. 5, 2023 | COO | 153,027 | $10.11 | Sell | $1,547,102.97 | |
| Oct. 2, 2023 | Director | 1,526,316 | $38.00 | Buy | $58,000,008.00 |
Insiders are both buying and selling Roivant Sciences Ltd stock.
The insider traders at Roivant Sciences Ltd are: Eric Venker, Rakhi Kumar, Matthew Gline, Vivek Ramaswamy, Mayukh Sukhatme, Sciences Ltd. Roivant, Pharma Technologies Ltd Dexcel, Financial Lp Qvt, Daniel Allen Gold, Frank Torti, Svf Investments (Uk) Ltd, Keith S Manchester, Melissa B Epperly, Global Investors Lp Viking, and Richard Pulik
The most active insider trader at Roivant Sciences Ltd is Eric Venker with 54 trades.
Svf Investments (Uk) Ltd has sold the most Roivant Sciences Ltd stock with a total value of $348,000,000.00.
Sciences Ltd. Roivant has bought the most Roivant Sciences Ltd stock with a total value of $734,300,410.00.
The most recent insider trade for Roivant Sciences Ltd was on March 17, 2026.
The single biggest insider buy for Roivant Sciences Ltd was from Sciences Ltd. Roivant with a total value of $336,900,200.00 on Jan. 13, 2025.
The single biggest insider sell for Roivant Sciences Ltd was from Global Investors Lp Viking with a total value of $128,700,000.00 on June 22, 2023.
